Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: J Public Econ. 2023 Mar 17;221:104860. doi: 10.1016/j.jpubeco.2023.104860

Table 5 –

Adherence of Chronic Drugs

Reduced Form
2SLS
Dependent Variable: I(High Adherence) Full Sample 2004–2007 2005–2007 Full Sample 2004–2007 2005–2007

(1) (2) (3) (4) (5) (6)
A. Instrument=Share65+ * Post
Post*Share65+ 0.184*** 0.234*** 0.404***
(0.057) (0.056) (0.114)
Views per Person (Non-Elderly) 0.017** 0.017*** 0.033***
(0.007) (0.005) (0.013)
B. Instrument=High Elderly Share * Post
High Elderly Share*Post 0.004* 0.008*** 0.012***
(0.003) (0.003) (0.004)
Views per Person (Non-Elderly) 0.008 0.011*** 0.021**
(0.005) (0.004) (0.008)
Mean of Dep. Var (pre- Part D) 0.61 0.61 0.56
Zipcode x Condition x Quarter Obs 102,477 59,252 44,519 102,477 59,252 44,519

Notes:

***

p<0.01,

**

p<0.05,

*

p<0.1. Clustered standard errors at the 3-digit ZIP code level; all specifications include quarter fixed effects, 3-digit ZIP code fixed effects, condition fixed effects. The outcome variable is the proportion of individuals with MPR>=80%. Includes the 50 drugs that advertised during the study period and the drugs that did not advertise for 5 chronic conditions: depression, diabetes, hyperlipidemia, hypertension, and osteoporosis.